Myc Target 1 anticorps (AA 21-100) (FITC)
Aperçu rapide pour Myc Target 1 anticorps (AA 21-100) (FITC) (ABIN728022)
Antigène
Voir toutes Myc Target 1 (MYCT1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 21-100
-
Réactivité croisée
- Humain, Souris, Rat
-
Homologie
- Dog
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human MTLC
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- Myc Target 1 (MYCT1)
-
Autre désignation
- MTLC
-
Sujet
-
Synonyms: MTLC, Myc target protein 1, Myc target in myeloid cells protein 1, MYCT1, MTMC1
Background: May regulate certain MYC target genes, MYC seems to be a direct upstream transcriptional activator. Does not seem to significantly affect growth cell capacity. Overexpression seems to mediate many of the known phenotypic features associated with MYC, including promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation (By similarity).
-
ID gène
- 80177
-
UniProt
- Q8N699
Antigène
-